http://www.fpnotebook.com/
Acyclovir
Aka: Acyclovir, Zovirax
- Indications
- Primary or Recurrent Herpes Simplex Virus Infection
- Oral Herpes (Herpes Labialis)
- Genital Herpes
- HSV Encephalitis
- HSV Keratitis
- Herpes Neonatorum
- Herpes Zoster
- Genital Herpes
- Varicella Zoster Virus (Chicken Pox)
- Herpes Zoster Ophthalmicus
- Herpes Labialis
- Pharmacokinetics
- Metabolized by Kidney
- Decrease interval in renal Impairment to q12-24h
- Dialysis: 50-100% dialyzable
- Pregnancy and Lactation
- FDA Pregnancy Class C
- Safety unclear in Breast Feeding
- How Supplied
- Tablets: 200, 400, 800 mg
- Suspension: 200 mg/5 ml
- Dosing: Systemic Acyclovir
- General
- Base Weight calculations on Lean Body Mass
- HSV Encephalitis or Herpes Neonatorum
- Child: 30 mg/kg/day (1500 mg/m2/day) divided q8h IV
- Primary Herpetic Gingivostomatitis
- Adult: 200 mg PO q4 hours while awake (5x/day)
- Ped: 15 mg/kg/d (750 mg/m2/d) divide q8h IV x5-10 day
- Initial Genital HSV
- Adult: 200 mg PO 5 times per day for 10 days
- Episodic Genital HSV
- Adult: 200 mg PO 5 times per day for 5 days
- Prophylaxis of Genital HSV
- Adult: 400 mg PO bid for up to 12 months
- Herpes Zoster (Shingles) or Herpes Ophthalmicus
- Adult Oral: 800 mg PO 5 times/day for 7-10 days
- Adult IV: 10-12 mg/kg/dose q8 hours for 7-14 days
- Varicella Zoster Virus (Chicken Pox)
- Child
- Dose: 10-20 mg/kg/dose to 800 mg PO qid for 5 days
- Adult
- Dose: 600-800 mg/dose PO q4h while awake (5x/day)
- Dose: 1000 mg/dose PO q6h for 5 days
- Intravenous
- Dose: 30 mg/kg/day (1500 mg/m2/day) divided q8h IV
- Dosing: Topical Acyclovir
- Initial genital HSV
- Apply to affected area 6 times per day for 7 days
- Adverse Effects
- Headache
- Gastrointestinal Upset
- Impaired Renal Function
- CNS depression
- Lethargy
- Confusion
- Coma
- Tremors
- Agitation
- Drug Interactions (prolong Acyclovir half life)
- Probenecid
- Zidovudine
- Precautions
- Overdose may result in Renal Failure
- Maintain adequate urine to flush renal tubules
- Efficacy: Herpes Labialis (Oral Herpes)
- Only effective if used at outset of symptoms
- Shortens Vesicle life and decreases shedding
- Prevents recurrence in immunocompromised
- Reduction in episodes: 53%
- Quicker healing: 4 days instead of 8 for Placebo
- Reduction in number of Fever Blisters: 71%